Medtech & Pharma Platform: establishment as an association strengthens activities and facilitates collaboration across pharma and medtech industries
Press release, Basel, 22 February 2017
In February 2017, the Swiss medtech industry organization, Medical Cluster, and the premium consulting company SFL founded the Medtech & Pharma Platform association. In doing so, the two founding members are building on the previous conferences’ success and strengthen their activities to foster cooperation between the medtech and pharma industries.
By establishing a forum to exchange knowledge and collaborate in technology and regulatory areas, the aim of the new association is to capitalize on the synergies between medtech and pharmaceutical industries and to promote product development and innovation.
The foundation of an association helps the Medtech & Pharma Platform to extend its activities beyond the annual conference which had its first meeting in 2014. Among other things, the founding members aim to strengthen advocacy work for companies to reduce time to market for drugs, devices and combinations thereof, improve access to innovative products, better match patients' needs and expand business opportunities for both industries.
For further information:
Medtech & Pharma Platform
c/o SFL Regulatory Affairs & Scientific Communication GmbH
Margarethenstrasse 47, CH-4053 Basel, Switzerland
Medical Cluster is the Swiss Medtech Association which aims to improve innovation for medical technology industry in Switzerland. Medical Cluster supports the interconnectivity between all stakeholders in the medical technology industry and provide fundamentals for a better understanding of the industry, its opportunities and challenges. This summer, Medical Cluster will merge with FASMED to form SWISS MEDTECH – the largest Medtech Association of Switzerland.
SFL Regulatory Affairs & Scientific Communication (SFL) is a premium consultancy specialized in life sciences. SFL’s highly skilled team has in-depth expertise for medicines, medical devices, diagnostics and combination products and provide personalized and integrated solutions from the bench to approval and reimbursement within one consultancy. SFL team expertise covers Regulatory Affairs, Public Affairs, Medical Affairs, Legal, Compliance, Pharmacovigilance, Quality Assurance, and Reimbursement.
The full press release can be downloaded using the link below: